What’s taking the Onconova Therapeutics Inc. (ONTX) stock to new heights?
Onconova Therapeutics, Inc. (ONTX), a clinical-stage biopharmaceutical company focused on commercializing novel products for the treatment of patients with cancer, announced today that the first patient has been dosed with rigosertib, for the Phase 2 study to evaluate the effectiveness and side effects of the drug, to assess drug reaction to people effected with recessive […]
